July 23 2004  


 

Veenendaal, The Netherlands, – Nucletron is pleased to announce receipt of 510(k) clearance from the U.S. Food and Drug Administration for Oncentra™ VISIR 2.0,record and verify system.  This major release provides numerous innovative record and verify features and unveils a completely redesigned user interface. Features include a comprehensive audit trail of all changes to patient data, support for dynamic MLC IMRT delivery, orthogonal mode for imaging and the unique ability to schedule portal images by protocol. 


VISIR 2.0 also includes an innovative Image Based Verification module that improves treatment accuracy by automatically comparing portal images to a reference image and determining patient displacement. A trend analysis of these positioning variances can be performed and a net adjustment can be made.  The corrective action is submitted directly into the record and verify system for the patient’s next treatment.  This is an industry first as no other image matching system closes the loop between image comparison and corrective action.


“VISIR  2.0 represents a vast amount of dedicated work which incorporates the requests from VISIR users.  Clinical input of our users enables us to provide a more advanced product that facilitates optimal patient care.  Our Image Based Verification demonstrates the next step in Adaptive Radiation Therapy and also includes protocol templates that can be applied to any patient.  This enables clinics to easily and consistently follow standard or research protocols for superior evidence based data” states Jan-Willem Hazenoot, Software Business Manager for Nucletron B.V.


About Nucletron

Nucletron specializes in the development, manufacture, sales, service and support of the world’s most innovative products for cancer treatment, with particular expertise in treatment planning, brachytherapy, information management, simulation and service.  The company has 22 offices worldwide, including its corporate headquarters in the Netherlands.  For more information on Nucletron please visit: www.nucletron.com



For further information:
Mark Adam
General Manager & V.P. Marketing
Phone: +31 318 557 149
E-mail: mam@nucletron.nl

Paula Waddell
Director of Marketing
Phone:  +1 410 312 4142
E-mail: Waddell@nucusa.com